Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

AMN Healthcare Honored as Prime Supplier of the Year for Work with Minority-Owned Businesses
AMN Healthcare Honored as Prime Supplier of the Year for Work with Minority-Owned Businesses


AMN Healthcare, the nation’s leader in healthcare total talent solutions, has been named Prime Supplier of the Year by the Western Regional Minority Supplier Development Council for prioritizing

DGAP-News: Cryptology’s estimated NAV per share as of 25/05/2022 is €6.55
DGAP-News: Cryptology’s estimated NAV per share as of 25/05/2022 is €6.55
DGAP-News: Cryptology’s estimated NAV per share as of 25/05/2022 is €6.55
Sberbank: Sber informs on the specific license for the depositary program unwinding
Sberbank: Sber informs on the specific license for the depositary program unwinding
Sberbank: Sber informs on the specific license for the depositary program unwinding
Eros Media World’s India Subsidiary Announces Equity Fund Raise: https://mms.businesswire.com/media/20220526005428/en/1468350/5/EMW_Final_Logo_On_White_Back.jpg
Eros Media World’s India Subsidiary Announces Equity Fund Raise


Eros Media World PLC (“ErosMedia”, “Eros" or the “Company”) (NYSE: ESGC), a global Indian media and entertainment company, announced today that the Board of Directors of Eros International Media

Jack in the Box Inc. Reports Second Quarter 2022 Earnings: https://mms.businesswire.com/media/20200729005173/en/808770/5/Jack_in_the_Box_Primary_Logo.jpg
Jack in the Box Inc. Reports Second Quarter 2022 Earnings


Jack in the Box Inc. (NASDAQ: JACK) announced financial results for the Jack in the Box segment in the second quarter, ended April 17, 2022, as well as the Del Taco segment on both a pro-forma

Model N CEO to Participate at the Jefferies 2022 Software Conference: https://mms.businesswire.com/media/20210902005040/en/902123/5/Model_N_Logo.jpg
Model N CEO to Participate at the Jefferies 2022 Software Conference


Model N, Inc. (MODN), a leader in revenue optimization and compliance, today announced that Jason Blessing, Chief Executive Officer, will present at the Jefferies 2022 Software Conference. The

Simulations Plus Releases ADMET Predictor Version 10.4 (X.4): https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, today announced the release of version 10.4 (X.4)

WICKES GROUP PLC: Result of Annual General Meeting
WICKES GROUP PLC: Result of Annual General Meeting
WICKES GROUP PLC: Result of Annual General Meeting
2022 Class of the Comcast NBCUniversal SportsTech Accelerator, Powered by Boomtown, Announce 21 Business Deals with Partnershttp://commons.wikimedia.org/wiki/File:Comlogo2012.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12106/Comlogo2012.png
2022 Class of the Comcast NBCUniversal SportsTech Accelerator, Powered by Boomtown, Announce 21 Business Deals with Partners


Today, Comcast announced the second class of the Comcast NBCUniversal SportsTech Accelerator, powered by Boomtown, has secured 21 pilots, partnerships, and commercial deals as a result of their

Novocure Announces Clinical Collaboration with MSD on a Registrational-Intent Study to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Newly Diagnosed Glioblastoma: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure Announces Clinical Collaboration with MSD on a Registrational-Intent Study to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Newly Diagnosed Glioblastoma


Novocure (NASDAQ: NVCR) today announced it has entered into a clinical trial collaboration agreement with MSD, a tradename of Merck & Co., Inc., Rahway, NJ, USA, to study the use of Tumor Treating

NICE Recognizes Innovators in Driving Frictionless Experiences, Unveiling CX Excellence Award Winners at Interactions Live 2022: https://mms.businesswire.com/media/20191203005409/en/615391/5/NICE_inContact.jpg
NICE Recognizes Innovators in Driving Frictionless Experiences, Unveiling CX Excellence Award Winners at Interactions Live 2022


NICE (Nasdaq: NICE) today announced the winners of its CX Excellence Awards 2022. The winning organizations were recognized for driving frictionless experiences throughout the customer journey. The

R.E.A. Holdings plc: Notification of Major Holdings
R.E.A. Holdings plc: Notification of Major Holdings
R.E.A. Holdings plc: Notification of Major Holdings
Wallbox Expands North American Presence to Support Growing Customer Demand: https://mms.businesswire.com/media/20211104005587/en/923671/5/%5BEUROPE%5DLogotype%2BIsotype_TM-b_%281%29.jpg
Wallbox Expands North American Presence to Support Growing Customer Demand


Wallbox (NYSE:WBX), a leading provider of electric vehicle (EV) charging and energy management solutions worldwide, today announced continued expansion in the North American market through

Biomind Labs Receives Approval for a Third Phase II Clinical Trial for Its 5-MeO-DMT Based BMND08 Candidate for Treatment of Depression and Anxiety in Alzheimer’s Disease: https://mms.businesswire.com/media/20220217005440/en/1363327/5/Biomind_Logo_2022.jpg
Biomind Labs Receives Approval for a Third Phase II Clinical Trial for Its 5-MeO-DMT Based BMND08 Candidate for Treatment of Depression and Anxiety in Alzheimer’s Disease


Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients

Pfizer Granted FDA Fast Track Designation for Ervogastat/Clesacostat Combination for the Treatment of Non-Alcoholic Steatohepatitis (NASH)http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Granted FDA Fast Track Designation for Ervogastat/Clesacostat Combination for the Treatment of Non-Alcoholic Steatohepatitis (NASH)


Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Pfizer’s investigational combination therapy for the treatment of

The Buckle, Inc. Reports First Quarter Net Income: https://mms.businesswire.com/media/20191107005107/en/222882/5/buckle-logo_hex.jpg
The Buckle, Inc. Reports First Quarter Net Income


The Buckle, Inc. (NYSE: BKE) announced today that net income for the fiscal quarter ended April 30, 2022 was $55.3 million, or $1.12 per share ($1.12 per share on a diluted basis).



Net sales for

500 Billion Gallons of Water Prevented from Flooding Communities in 2021, Using Xylem Technology: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24843/Xylem_Logo.png
500 Billion Gallons of Water Prevented from Flooding Communities in 2021, Using Xylem Technology


Solutions from global water technology company Xylem (NYSE:XYL), helped prevent more than 500 billion gallons of polluted water from flooding communities in 2021, according to its annual

Gresham Worldwide, a BitNile Holdings Subsidiary, Booked New Orders Exceeding $8.6 Million in the First Quarter of 2022: https://mms.businesswire.com/media/20220512005443/en/1267458/5/Bitnile_Logo_%28300ppi%29.jpg
Gresham Worldwide, a BitNile Holdings Subsidiary, Booked New Orders Exceeding $8.6 Million in the First Quarter of 2022


BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or the “Company”), announces its global defense business, Gresham Worldwide, Inc. (“Gresham Worldwide”)

Form 8.3 - The Vanguard Group, Inc.: THG plc
Form 8.3 - The Vanguard Group, Inc.: THG plc
Form 8.3 - The Vanguard Group, Inc.: THG plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Petrofac Limited: Board Changes
Petrofac Limited: Board Changes
Petrofac Limited: Board Changes
WICKES GROUP PLC: Appointment of Joint Corporate Broker
WICKES GROUP PLC: Appointment of Joint Corporate Broker
WICKES GROUP PLC: Appointment of Joint Corporate Broker
Petrofac Limited: RESULTS OF ANNUAL GENERAL MEETING
Petrofac Limited: RESULTS OF ANNUAL GENERAL MEETING
Petrofac Limited: RESULTS OF ANNUAL GENERAL MEETING